Yili Chuanning Biotechnology Co.,Ltd. engages in the research and development, and industrialization of biological fermentation technology in China. The company offers antibiotic intermediates, such as erythromycin thiocyanate, penicillin G potassium salt, 6-aminopenicillanic acid, 7-aminocephalosporanic acid, 7-aminodesacetoxycephalosporanic acid, and ursodeoxycholic acid. Yili Chuanning Biotechnology Co.,Ltd. was incorporated in 2010 and is based in Yining, China. Yili Chuanning Biotechnology Co.,Ltd. operate as a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd.
Metrics to compare | 301301 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301301PeersSector | |
---|---|---|---|---|
P/E Ratio | 20.3x | 30.3x | −0.5x | |
PEG Ratio | 1.00 | −0.63 | 0.00 | |
Price/Book | 3.3x | 2.4x | 2.6x | |
Price / LTM Sales | 4.9x | 6.5x | 3.1x | |
Upside (Analyst Target) | 23.2% | 19.9% | 47.8% | |
Fair Value Upside | Unlock | 21.5% | 6.9% | Unlock |